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Abstract 
Although cone-beam CT(CBCT) has been used to guide irradiation for pre-clinical 
radiotherapy(RT) research, it is limited to localize soft tissue target especially in a low imaging 
contrast environment. Knowledge of target shape is a fundamental need for RT. Without such 
information to guide radiation, normal tissue can be irradiated unnecessarily, leading to 
experimental uncertainties. Recognition of this need led us to develop quantitative 
bioluminescence tomography(QBLT), which provides strong imaging contrast to localize optical 
targets. We demonstrated its capability of guiding conformal RT using an orthotopic 
bioluminescent glioblastoma(GBM) model. With multi-projection and multi-spectral 
bioluminescence imaging and a novel spectral derivative method, our QBLT system is able to 
reconstruct GBM with localization accuracy <1mm. An optimal threshold was determined to 
delineate QBLT reconstructed gross target volume(GTVQBLT), which provides the best overlap 
between the GTVQBLT and CBCT contrast labelled GBM(GTV), used as the ground truth for the 
GBM volume. To account for the uncertainty of QBLT in target localization and volume 
delineation, we also innovated a margin design; a 0.5mm margin was determined and added to 
GTVQBLT to form a planning target volume(PTVQBLT), which largely improved tumor coverage 
from 75%(0mm margin) to 98% and the corresponding variation(n=10) of the tumor coverage was 
significantly reduced. Moreover, with prescribed dose 5Gy covering 95% of PTVQBLT, QBLT-
guided 7-field conformal RT can irradiate 99.4±1.0% of GTV vs. 65.5±18.5% with conventional 
single field irradiation(n=10). Our QBLT-guided system provides a unique opportunity for 
researchers to guide irradiation for soft tissue targets and increase rigorous and reproducibility of 
scientific discovery. 
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Significance: We have presented a comprehensive approach to systematically tackle the 
challenging of BLT for in vivo target delineation, quantify its uncertainties in localization, and 
demonstrate the practicality for radiation guidance.  
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Introduction  
Several groups, including ours, have initiated efforts to develop small-animal irradiators that 
mimic radiation therapy (RT) for human treatment (1-4). The major image modality used to guide 
irradiation is cone-beam computed tomography (CBCT). Our CBCT-guided small animal 
radiation research platform (SARRP), and others, were transformative for pre-clinical RT research, 
and more than 115 machines are now in use world-wide by some 600 investigators. While CBCT 
provides excellent guidance capability (5-7), it is less adept at localizing soft tissue targets growing 
in a low image contrast environment. This challenging limit RT studies using important orthotopic 
models.  
Bioluminescence imaging (BLI) provides strong image contrast and thus is an attractive 
solution for soft tissue targeting. With the wide availability of genetically engineered mouse 
models, BLI has been used extensively in pre-clinical cancer research to track malignancy and 
assess its activity. BLI is commonly acquired at a non-contact imaging geometry (8-10), based on 
measurement of emitted surface light from an internal source. Although almost all commercially 
available systems use the 2D BLI superimposed onto a textured image of an animal to track target 
activity, this imaging modality are far from being applied to quantify spatial source distributions 
and to guide focal irradiation (11,12). The inadequacy of using BLI for focal irradiation is 
attributed to the optical transport from an internal bioluminescent tumor, which is highly 
susceptible to irregular animal torso and tissue absorption and scattering. 
Recognition of these limitations led us to integrate 3D bioluminescence tomography (BLT) 
with small animal irradiators. BLT allows the recovery of volumetric distribution of 
bioluminescent source based on surface BL emission (13-16). Our first BLT was designed to 
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localize the center of mass (CoM) of an optical target for irradiation (11,17). This advance was 
received with much intrigue, however there was little practical adoption of the BLT system by RT 
researchers. It was clear that the investigators required the unmet need to be addressed, to 
significantly enhance their conduct of research. First, knowledge of target shape is a fundamental 
need for RT. Without such information to guide radiation, large portions of normal tissue can be 
irradiated unnecessarily, leading to undesired experimental uncertainties. It is imperative that we 
advance BLT guidance beyond CoM, to a new and precise level of 3D target shape delineation. 
Second, clinical practice recognizes the importance of complementary use of functional and 
anatomical image such as positron emission tomography (PET)/CT, for radiation treatment 
planning and for tumor response evaluation. BLI measures cellular viability (10), thus it is an ideal 
imaging modality for longitudinally monitoring treatment outcome. However, the quantitative 
information that surface BLI provides for assessment is currently limited or even inaccurate. With 
the novel reconstruction algorithm and calibration methods proposed in this work, we establish a 
new quantitative BLT (QBLT) to address this need. We expect that the QBLT/CBCT-guided 
SARRP will provide investigators unprecedented capabilities to localize soft tissue target, define 
its shape for conformal irradiation, and non-invasively quantify treatment outcome.   
In BLT, a model of light propagation through tissue to the skin surface is employed, in 
conjunction with an optimization algorithm, to reconstruct the underlying 3D source spatial 
distribution, which minimizes the difference between calculated and measured surface BL signal. 
For our QBLT imaging workflow, mice were subject to bioluminescence imaging, and later 
SARRP CBCT imaging, followed by BLI mapped to animal CBCT image and QBLT 
reconstruction to retrieve target distribution. The CBCT image was acquired to generate 
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anatomical mesh for the reconstruction and radiation treatment planning. To apply QBLT as an 
image-guided system for conformal irradiation in vivo, we have optimized hardware configuration, 
algorithm, calibration methods, and radiation margin. 1) A multi-projection and multi-spectral 
bioluminescence imaging system was developed to maximize input data points and improve the 
stability of QBLT reconstruction. 2) The multi-spectral BLT heavily relies on the accurate 
quantification of the emission spectrum of bioluminescent tumor cells and the dynamic change of 
in vivo signal. The investigation and corresponding methodology of quantifying the spectrum and 
in vivo signal are presented. 3) Non-contact imaging geometry is commonly adopted in optical 
tomography, but the challenge of accurately accounting light propagation from tissue surface to 
optical detector remains. A novel spectral derivative (SD) BLT algorithm was proposed recently 
(16) and first applied to animal studies. This new algorithm effectively eliminated the known issue 
of free space light propagation error and significantly facilitated QBLT shape delineation and 
quantitative capability. 4). To ensure radiation coverage and account for QBLT uncertainties in 
target localization, we have systematically devised target margin in line with clinic practice for 
radiation guidance, which made QBLT possible for image-guided RT research.  
An orthotopic glioblastoma (GBM) model was chosen as the testing platform to demonstrate 
the QBLT-guided RT, because its low imaging contrast represents a challenging case for CBCT-
guided system. This work is the first systematic study demonstrating the BLT-guided conformal 
irradiation for orthotopic model in vivo. Our proposed QBLT platform will significantly enhance 
pre-clinical RT research with the capabilities of functional targeting beyond anatomical imaging. 
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Materials and Methods 
System Configuration  
Our optical system consists of an optical assembly, a mobile cart and a transportable mouse bed 
(Fig. 1A). The optical assembly is driven by a 1D motorized stage to dock onto an independent 
mouse bed for optical imaging. The optical assembly includes a CCD camera(iKon-L 936, 16 bit, 
Andor Technology, Belfast, UK) mounted with a 50-mm f/1.2 lens (Nikkor, Nikon Inc., Melville, 
NY), a filter wheel (Edmund Optics Inc., Barrington, NJ), a 3-mirror system (98% reflective, 
protected silver coating) and a light enclosure (Fig. 1B). The filter wheel with optical filters is used 
for multi-spectral image acquisition to improve BLT reconstruction accuracy (15,18,19). The 
optical signal emitted from the surface of an imaged object was directed to the CCD by the 3-
mirror system. Each mirror is 45° relative to optical path as shown by the red dashed line in Fig. 
1B. Four 20-nm FWHM band-pass filters (Chroma Technology Corp., Bellows Falls, VT) with 
center wavelength at 590, 610, 630 and 650 nm were used. The 3-mirror system can rotate 1800 
(from -90° to 90°) around imaged object for multi-projection imaging. The optical image taken at 
top of the mouse bed is labeled as 0° projection imaging. In preparation of the imaging session, 
the imaging chamber was first warmed up by a heat gun (Fig. 1A) and the temperature was 
maintained at 37 °C by a resistor loop built inside the imaging chamber. Four fans were placed at 
the front corners, 2 at each corners, and 3 fans were placed on the front-top end of the chamber to 
circulate the hot air generated from the thermistor to maintain uniform temperature throughout the 
chamber. The calibration procedure for image uniformity was bypassed since ratio image instead 
of conventional spectral image was used as the input data for the SD-method based QBLT 
reconstruction. The detailed characterization of the optical system is described in the 
8 
 
 
 
 
supplementary material Sec. 1. 
After optical imaging, the mouse bed (Fig. 1C) with imaged animal can be readily transferred 
from the optical system to the SARRP (Xstrahl Inc., Suwanee, GA) for CBCT imaging and 
irradiation. On the bed, there are 8 imaging markers (Chemical-Resistant Slippery PTFE Balls, 2.4 
mm diameter, McMaster-carr, Santa Fe Springs, CA) used for data mapping purpose to register 
surface BLIs with 3D CBCT image. Our SARRP consists of an X-ray source, a 20.5 x 20.5 cm2 
amorphous silicon flat panel detector with 200-μm pixel (Perkin-Elmer, Waltham, MA) and a 4D 
(x, y, z translation and 360° rotation) robotic couch (Fig. 1D). The X-ray source was performed at 
65-kVp and 7-mA for CBCT imaging and at 220-kVp and 13-mA for irradiation. CBCT imaging 
is acquired by rotating the prone animal between the stationary X-ray source and detector panel. 
The combination of a 360° isocentric gantry and the 4D robotic couch allows SARRP perform 
non-coplanar radiation delivery. Studied animal was anesthetized by anesthetic gas through nose 
cone and gas tube and immobilized during the imaging sessions and transport. The optical system 
was operated within 2 meters to the SARRP to minimize the impact of animal transport on the 
animal position (20). After optical and CBCT imaging, QBLT reconstruction was conducted, and 
the reconstructed bioluminescent tumor volume was used to guide SARRP irradiation.  
Data mapping for multi-projection imaging 
Because CBCT imaging defines the coordinate used for QBLT reconstruction, our geometry 
calibration method published in Ref. (21) was used to map the 2D optical images acquired at 
multiple viewing planes onto the animal surface of the 3D CBCT image. The mapped BLIs were 
used as the input data for QBLT reconstruction. Our method has two steps: 1) mapping the CBCT 
coordinate to the 3D optical coordinate with rigid transformation, and then 2) projecting the 3D 
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optical coordinate to the 2D optical (CCD) imaging plane. After the 3D CBCT and 2D optical 
coordinates are registered, for a given projection, we can then map the surface BLI to the CBCT 
image. The data mapping process requires knowledge of the geometrical parameters of our system. 
The imaging markers on the mouse bed (Fig. 1C) can be located in both CBCT and 2D optical 
images. Inside the optical imaging chamber (Fig 1A), there are LED light sources for photo 
imaging to identify the animal position and the imaging marker. An optimization routine with the 
constrained multivariable optimization function (fmincon, MATLAB, The MathWork Inc., Natick, 
MA) has been developed to retrieve the geometrical parameters by minimizing the difference 
between the calculated and measured marker positions in the 2D optical coordinate; the marker 
positions at -90°, -45°, 0°, 45° and 90° optical projection were used as the measured marker 
positions, and the corresponding marker positions retrieved from the optimization routine based 
on the optimized geometrical parameters and the markers positions in 3D CBCT were used as the 
2D calculated marker positions. The geometric calibration was performed for each animal imaging 
session to ensure accurate data mapping for QBLT reconstruction. 
To validate the accuracy of our data mapping method, 11 plastic imaging markers were placed 
on a mouse phantom (XFM-2, Perkin Elmer Inc., Waltham, MA) and imaged at -90°, 0° and 90° 
projections, which are the projections commonly used in our QBLT. The measured positions of 
these 11 plastic markers on the 2D optical image were used to verify the corresponding marker 
positions calculated from our data mapping method.  
System-specific cell spectrum  
Because of the multi-spectral BLT approach, it is important to quantify the system spectral 
response, including optics, filter and camera, and the emission spectrum of bioluminescent targets. 
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Since the choice of BL wavelength is fairly standard, for simplicity, we used the QBLT (Fig. 1A) 
system to measure the source spectrum, e.g. GBM cells in this work. The measurement includes 
the system and cell spectral response, and we called the resulted spectrum as system-specific cell 
spectrum. Therefore, the wavelength dependent BLIs can be normalized to the measured spectrum 
weighting, used as the input data for our reconstruction algorithm. We measured the system-
specific spectral weights of GL261-Luc2 cells at 590, 610, 630 and 650nm in petri dishes (NuncTM 
cell culture treated multidishes, ThermoFisher Scientific, Waltham, MA, 35mm in diameter, 1x106 
cells/dish, 50l luciferin/dish at 30mg/ml). We acquired the BLIs in our imaging chamber kept at 
37 oC (Fig. 1A). Open field images without filters were taken before and after each spectral BLI 
to quantify the in vitro signal variation over time. The time point for each image was recorded and 
the open field images were used to generate an in vitro time-resolved signal curve. To eliminate 
the change of the in vitro spectral signal as function of luciferin incubation time, we normalized 
the intensity of the multi-spectral BLIs taken at different time points to the in vitro time-resolved 
curve. The measured spectrum of the GL261-Luc2 at 590, 610, 630 and 650 nm at 37 °C are 1, 
0.916 ± 0.014, 0.674 ± 0.019, 0.389 ± 0.012(n = 20), respectively. It is worthwhile to mention that 
even for the same cell line, with different luciferase, the BL spectrum can be different. For the 
sake of readers’ interest, the measured spectrum of GL261 cells tagged with another luciferase 
gene RedFluc is shown in Fig. S2. 
To assess the spectrum change as function of ambient temperature, we compared two conditions 
24 and 37 °C which represent our BLT system setting without and with the thermo system turned 
on. We also confirmed the system temperature reading by measuring the temperature of the 
phosphate buffer solution incubated with cells during the BLI acquisition using an infrared 
11 
 
 
 
 
thermometer (Lasergrip 774, ETEKCITY, Anaheim, CA, USA).     
Quantify in vivo bioluminescence signal variation overtime 
Because in vivo bioluminescence signal can vary overtime and the change can be animal 
specific, it is important to quantify the time-resolved in vivo signal for having accurate input data 
for QBLT reconstruction. For this purpose, a time-resolved bioluminescence signal curve was 
established for each imaged animal. To build the time-resolved curve for each projection during 
BLI acquisition, open field images taken before and after each spectral image along with the time 
points when the images were taken were used to record the signal variation overtime. A region of 
interest (ROI) was chosen in the open field image. Because the ROIs in different projection was 
not from the same physical location of animal surface, the time-resolved curves between two 
adjacent projections were linked by extrapolating the light intensity from the time-resolved curve 
of the first projection to the time point when the first open field image at the second projection was 
measured. The light intensity recorded from the second projection at this time point was scaled 
according to the extrapolated light intensity from the first projection. By using this method, we 
can combine the time-resolved curves among different projections and quantify the dynamic 
change of in vivo bioluminescence signal during the optical image course. Based upon the time-
resolved signal curve, we can correct the intensity of each spectral image taken at certain time 
point.  
Mathematical framework for QBLT reconstruction 
Because light transport in tissue is dominated by scattering, Diffusion Approximation (DA) of 
the light transport equation was applied in our work to model the light propagation in tissue media 
(22). In continuous wave mode, the DA with the Robin-type boundary condition is expressed as: 
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{
−∇ ∙ 𝐷(𝑟)∇Φ(𝑟) + 𝜇𝑎(𝑟)Φ(𝑟) = 𝑆(𝑟), 𝑟 ∈ Ω
Φ(𝜉) + 2𝐴?̂? ∙ 𝐷(𝜉)∇Φ(𝜉) = 0, 𝜉 ∈  𝜕Ω
 (1) 
where Φ(𝑟) is the photon fluence rate at location r in domain Ω, 𝐷(𝑟) = 1/(3(𝜇𝑎 + 𝜇𝑠
′ )) is the 
diffusion coefficient, and 𝜇𝑎  and 𝜇𝑠
′  are absorption and reduced scattering coefficients, 
respectively at a given wavelength λ. 𝑆(𝑟) is the bioluminescence source distribution. ξ represents 
points on the tissue boundary, and coefficient A can be derived from Fresnel’s law, depending on 
the refractive index of tissue and air. ?̂? is the unit vector pointing outward, normal to the boundary 
𝜕Ω. Equation 1 can be further expressed in the form of linear function:  
 𝐺𝜆𝑤𝜆𝑆 =  𝜑𝜆 (2) 
where 𝐺𝜆  is the mapping function describing the changes of boundary/surface fluence rate 𝜑𝜆 
related to source S for a given wavelength λ, and 𝑤𝜆 is the relative spectrum of the light source of 
interest. 𝐺𝜆 can be constructed from prior knowledge of the optical property of subject. 
In non-contact imaging geometry as shown in Fig. 1B, one major challenging is accounting for 
the light propagation from animal surface to the optical detector (e.g. camera in our system). We 
have developed a new approach (16) in which the spectral derivative of that data (the ratio of the 
surface images at adjacent wavelengths) is used, as bioluminescence at similar wavelengths 
encounters a near-identical system response. The system response can be expressed by rewriting 
the fluence rate 𝜑𝜆 =  𝑏𝜆𝑛, where n is a measurement point specific angular dependent offset to 
account for the difference between actual surface fluence rate 𝜑𝜆 and BLI measurement 𝑏𝜆, and n 
is assumed to be spectrally invariant. The Eq. (2) becomes 
 𝐺𝜆𝑤𝜆𝑆 = 𝑏𝜆𝑛 (3) 
. By applying logarithm to Eq. (3) and considering the ratio of the data between two neighboring 
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wavelengths λi and λi+1, we can write the spectral derivative form of Eq. (3) as Eq. (4): 
 [
log 𝑏𝜆𝑖𝑛
𝑏𝜆𝑖𝑛
𝐺𝜆𝑖𝑤𝜆𝑖 −
log 𝑏𝜆𝑖+1𝑛
𝑏𝜆𝑖+1𝑛
𝐺𝜆𝑖+1𝑤𝜆𝑖+1] 𝑆 = log
𝑏𝜆𝑖
𝑏𝜆𝑖+1
 (4) 
. The source distribution S in the spectral derivative form (Eq. 4) can be iteratively solved by 
applying CSCG optimization algorithm (23) with multi-spectral and multi-projection data. The 
mapping function (also often referred to as weight or sensitivity function) was generated by a 
modified version of the open source NIRFAST software (24).  
In vivo QBLT validation 
In vivo procedures were carried out in accordance with the Johns Hopkins Animal Care and 
Use Committee. To establish GBM model, GL261-Luc2 cells (1.2 x 105 cells in 2l phosphate-
buffered saline, PH 7.4, gibco, ThermoFisher Scientific, Waltham, MA) was stereotactically 
implanted into the left striatum of mouse (C57BL/6J, female, 6-8 weeks old) at 3mm depth. The 
GBM-bearing mice 2 weeks after cell implantation were subject to QBLT imaging session. Before 
optical imaging, mouse hair was shaved, followed by hair depilation. D-Luciferin (125l, 30mg/ml 
injection for 25g mouse to reach 150mg/kg, XenoLight D-Luciferin K+ Salt, PerkinElmer, Inc., 
Waltham, MA) was administrated via intraperitoneal injection. Mouse at prone position was 
subject to BL imaging 10 minutes after the luciferin injection. During imaging, mouse was 
anesthetized with 1-2% isoflurane (Fluriso, MWI Veterinary Supply Co. Boise, ID) in oxygen. 
Multi-spectral BLIs at 590, 610, 630 and 650 nm and open field images at multi-projection (0°, 
90° and -90°) were acquired at 8x8 pixel binning (approximately 1 mm at our imaging plane). The 
imaging acquisition time for our GL261-Luc2 model at 2-weeks old (tumor volume range: 4-18 
mm3) is about 2-20 and 10-120 sec for open and spectral image, respectively, to achieve 
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approximate 3800-28000 and 1800-18000 image counts after background subtraction.  
Photo images at -90°, -45°, 0°, 45° and 90° projections were taken to retrieve the positions of 
fiducial markers for the geometrical calibration after the BLIs acquisition. Because the in vivo 
signal at 590 nm was weak compared to that of other spectral image, which affects the stability of 
the spectral derivative method, for the results presented following, we chose the images at 610, 
630, and 650 nm for QBLT reconstruction process. The BLIs were then mapped onto the 3D mesh 
surface of the imaged mouse generated from the CBCT image. At the overlapped region on the 
mesh surface, for a given node between two mapped images from different projections, the 
maximum value of the two images was chosen as the value on that surface node. The mapped 
surface data larger than 10% of the maximum value among all the surface points were used as 
input data for QBLT reconstruction. The published values (25) of 𝜇𝑎 0.1610, 0.0820 and 0.0577 
mm-1 and 𝜇𝑠
′  1.56, 1.51 and 1.46 mm-1 of mouse brain for 610, 630 and 650 nm, respectively, were 
used for QBLT reconstruction. The detail of numerical parameters used in QBLT reconstruction 
can be found in supplementary material Sec. 3.  
Contrast CBCT was used to define the gross target volume (GTV) of GBM bearing mice as the 
ground truth to validate the accuracy of QBLT target localization. After QBLT imaging session, 
imaged mouse was moved to our in-house high resolution CBCT system (26) for the contrast 
imaging. Iodixanol agent 160l at 320mgI/ml (Visipaque, GE Health Care, Chicago, IL) was 
administrated through retro-orbital injection. The mouse was imaged 1 minute after the injection. 
Mouse head region was cropped in both SARRP CBCT image and contrast CBCT image, and the 
cropped contrast CBCT image was registered to that of SARRP CBCT image by General 
Registration (BRAINS) module in 3D Slicer (27). The GTV was first segmented in 3D Slicer (see 
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supplementary material Sec. 4 for detail) and then compared that to the GTV reconstructed by 
QBLT (GTVQBLT). We determined the threshold, based upon maximum value of QBLT 
reconstructed power density distribution (S, Eq. (3)), which best delineates the GTVQBLT, by 
analyzing the Dice coefficient between GTVQBLT and GTV, as 2(GTVQBLT ∩ GTV)/(GTVQBLT +
GTV). 
In vivo QBLT-guided conformal irradiation 
A margin accounting for the uncertainty of QBLT target localization (e.g. positioning and target 
volume determination) was added to GTVQBLT to form a planning target volume (PTVQBLT) for 
radiation guidance. We generated 7 field conformal radiation plan using SARRP treatment 
planning system, MuriPlan, with the goal of 5Gy as the prescribed dose to cover 95% of the 
PTVQBLT and 100% of the GTVQBLT. To qualitatively confirm the QBLT-guided GBM irradiation, 
we perform the pathological analysis with immunohistochemical staining (see supplementary 
material Sec. 5 for the detail of staining procedure) to visualize cell nuclei and DNA double-strand 
breaks using 4’, 6-diamidino-2-phenylindole (DAPI) and γ-H2AX, respectively. 
Data distribution and statistical analysis 
Non-parametric box plots (MATLAB R2019b, MathWorks, Natick, MA) were used to display 
distributions of the Dice coefficients as function of threshold values, tumor and normal tissue 
coverage as function of PTVQBLT margin size, and dosimetric parameters for single field and 
QBLT-guided plan comparison. The area between the bottom (25th percentile), and top (75th 
percentile) of the box edge indicates the degree of data spread. The “black band” within the box 
represents the 50th percentile, or the median number. The outlier is defined as the data falling 
outside the range of q3 + w × (q3 – q1) to q1 – w × (q3 – q1), where w is the maximum whisker 
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length, and q1 and q3 are the 25th and 75th percentiles of the sample data, respectively. The default 
value of w equal to 1.5 was used in our study which corresponds to approximately 99.3% coverage 
if data are normally distributed, but it is not assumed in our study. 
Statistical significance of differences in averages was determined using a two-tailed paired 
student t test (t.test function, Microsoft® Excel® 2016, Microsoft Co. Redmond, WA). A p value 
less than 0.05 was considered significant for all statistical analysis. 
Results 
Data registration: 2D BLIs mapped to the mesh surface from 3D CBCT  
The procedure and validation of 2D BLIs mapped to the mesh surface generated from 3D CBCT 
is demonstrated in Fig. 2. Fig. 2A shows 8 fiducial markers used to retrieve the geometrical 
parameters of our optical system for data mapping. To assess the accuracy of the data registration, 
we taped 11 plastic balls on the phantom. The positions of these 11 plastic balls were directly 
measured from the 2D optical images taken at -90°, 0° and 90° projection, and were compared to 
the corresponding positions (Fig. 2B) calculated by our calibration routine. The average and 
standard deviation between the measured and calculated positions of the plastic balls is 0.26 ± 
0.03mm (n=6). The maximum deviation is 0.56 mm over all the plastic balls and the test samples. 
This result indicates we can register 2D optical to 3D CBCT coordinate at sub millimeter accuracy. 
A mouse phantom embedded with a self-illuminated rectangular light source (9.8mm x 2.8mm 
x 2mm, Trigalight, Mb-Microtec ag, Niederwangen, Switzerland) was chosen to demonstrate the 
data mapping procedure for multi-projection QBLT. Fig. 2C and D show, respectively, the BLIs 
of the mouse phantom taken at -90°, 0° and 90° projections, and mapped to the numerical mesh 
surface generated of the phantom CBCT image. The mapped data (Fig. 2D) is the input data for 
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QBLT reconstruction. 
The impact of ambient temperature and the quantification of inter-animal signal variation 
In this section, we demonstrate the impact of ambient temperature on the system-specific cell 
spectrum and the importance of quantifying inter-animal signal variation for quantitative BLT. 
Fig. 3A shows in vitro BL intensity of the GL261-Luc2 cells can increase significantly as the 
ambient temperature increased; from 24 °C to mouse body temperature 37 °C, the intensity can be 
increased by 2-fold. Beyond maintaining normal physiological function, keeping animal at the 
body temperature during BL imaging session is also favorable to shorten the image acquisition 
time, and therefore increase throughput. Fig. 3B further illustrates the emission spectrum of the 
GL261-Luc2 cells can be red-shifted, when ambient temperature is increased. This result 
emphasizes to achieve QBLT, it is critical to maintain a consistent temperature control between in 
vitro cell spectrum measurement and in vivo experiment.  
Fig. 3C shows the time-resolved in vivo BL signal, after D-Luciferin was administrated, is 
animal-specific. For each imaged animal, as one can take spectral BLIs at different time points, 
the animal-specific signal variation could largely affect the accuracy of the input spectral BL data. 
We use the mouse 3 from the Fig. 3C as an example to show, with the method described in the 
section of Materials and Methods, we were able to build the animal-specific time-resolved 
bioluminescence curve over the entire multi-projection imaging course. With this curve, we can 
eliminate the effect of inter-animal and physiological variation on each spectral BLI taken at a 
certain time point, used as the input data for QBLT. 
In vivo QBLT 
To demonstrate the QBLT capability in delineating 3D target in vivo, GBM-bearing mice 2 
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weeks after GL261-Luc2 implantation were used for BL imaging and reconstruction. Fig. 4A-B 
shows the BLIs taken at -90°, 0° and 90° 3-mirror position (Fig. 4A), and then mapped to the 
numerical mesh surface generated from the mouse CBCT image (Fig. 4B). The corresponding 
QBLT reconstructed GBM, GTVQBLT, is qualitatively matched to the contrast-labelled GBM, GTV 
(Fig. 4C-E), if a threshold 50% (0.5) of maximum QBLT reconstructed value (BL power density) 
was applied. We further justify the 0.5 threshold as the optimal value for QBLT in target 
delineation using Dice coefficient (Fig. 4F). We observed at threshold 0.5, there is a most 
overlapped volume between the GTVQBLT and GTV. Furthermore, although there is no significant 
difference of the Dice coefficient between the threshold 0.5 and 0.6 groups, the variation of the 
data spread is smaller, and the median value of the Dice coefficient is larger for the threshold 0.5 
group than that for the 0.6 group. These reasons support our choice of picking the 0.5 threshold 
value to delineate the GTVQBLT. As the threshold was continuously increased, GTVQBLT became 
smaller, and deviated from the contrast-labelled GBM GTV, which introduced larger data spread 
as shown in the cases of threshold 0.7-0.8. Moreover, the deviation of CoMs between GTVQBLT 
and GTV is 0.62 ± 0.16 mm for our GBM animal cohort (n=10). The individual 10 mice results of 
the GTVQBLT coverage can also be found in Fig. S3. 
Margin design for PTVQBLT 
Although the GTVQBLT qualitatively matches the true GBM volume GTV (Fig. 4C-E), there is 
still deviation between the two quantities in terms of volume and positioning. To effectively 
account for these deviations and ensure irradiation coverage of the tumor volume, we added a 
uniform margin to GTVQBLT and form the PTVQBLT for radiation guidance (Figs. 5A and S3). We 
also investigated the optimal margin size by evaluating the GBM volume coverage with conformal 
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index of  (PTVQBLT ∩ GTV)/GTV  and normal tissue coverage with (PTVQBLT − PTVQBLT ∩
GTV)/Vhead , where Vhead is the volume of mouse head (Fig. 5B). Without margin (0mm 
expansion), large variation of tumor coverage is expected. We observed with merely 0.5mm 
margin expansion, the GTV can be covered by the PTVQBLT at 97.9 ± 3.5% (capped at 100%) with 
much smaller variation compared to the case of 0mm margin, while the normal tissue inclusion is 
only at 1.2 ± 0.3%. As we further increased the margin, the benefit of tumor coverage is not 
statically significant but obviously, more normal tissue toxicity is introduced. We therefore chose 
0.5mm margin for our QBLT-guided GBM studies described below. 
In vivo QBLT-guided conformal irradiation  
Fig. 6A1-3 show a representative case of a 7-field non-coplanar beam arrangement to cover the 
PTVQBLT on the GBM bearing mice, shown in Fig. 5A. A 5x5 mm
2 square beam collimator was 
used, and the CoM of GTVQBLT was set as the beam isocenter (pink points). The corresponding 
dose distributions are shown in Fig. 6B1-B3, where 5Gy (red line) was prescribed to cover 95% 
of the PTVQBLT. Although we were limited by available collimator size, the QBLT-guided 7-field 
conformal plan can still effectively cover the PTVQBLT and GTV. For comparison, we generated 
the dosimetric plan of single beam irradiation (Fig. 6C1-C3), commonly used in radiobiology 
studies (28-30). The single field irradiation was guided by the surgical opening at the skull surface 
indicated in the CBCT, and the 5Gy was prescribed to the cell implementation site 3mm away 
(yellow dots) from the opening. Clearly, the single field plan underdose the GTV (red line vs. blue 
contour), and led to undesired normal tissue irradiation. The dose-volume histogram (DVH, Fig. 
6D) shows 100% of GTV covered by the 5Gy prescribed dose with the 7-field conformal plan, and 
in contrast, only 54% coverage is seen from the single field plan. The GTVQBLT is also 100% 
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covered by the 7-field plan. It is expected that the 7-field plan introduced larger portion of low 
dose bath in normal tissue region, which is a trade-off for high conformality of target coverage and 
reduction of the normal tissue toxicity at high dose. From our mice cohort (n=10), with QBLT-
guided conformal irradiation, we can achieve 100% of the prescribed dose covering 99.4±1.0% 
(capped at 100%) of GTV versus 65.5±18.5% coverage with the single field irradiation. We further 
compare the target volume coverage for the single field and QBLT-guided 7-field plan using the 
metrics of D100, D50 and D2 (Fig. 6E). Taking the D100 as an example, it is the deposited dose being 
able to cover 100% of the GTV. These metrics indicate the dosimetric heterogeneities introduced 
by a given irradiation technique. The D100 boxplot shows that none of the single-field plan can 
deliver the prescribed dose 5Gy covering 100% of GTV, and 40% of the animals did not even 
reach D100 at 4Gy level. The large box size and extensive D100 variation, 0.1 to 4.9 Gy, renders 
large experimental uncertainty. In contrast, for QBLT-guided 7-field irradiation, D100 of GTV only 
vary from 4.9 to 5.5Gy within 25-75% data range, with minimum 4.5Gy, maximum 6.2Gy, and 
median value at 5.2Gy, which indicates superior tumor coverage and smaller dose variation. The 
larger spread of D50 and D2 shown in both 7-field GTV and GTVQBLT, compared to the single field 
group, can be attributed to the limited size of the available collimators, and the same treatment 
plan (couch and gantry setting) applied for this mice cohort. It led us use different isodose line as 
the prescribed dose to cover PTVQBLT. We further compared the D100, D50 and D2 between the GTV 
and GTVQBLT group, and there is no significant difference between these metrics. It suggests one 
could use GTVQBLT to evaluate the dosimetric coverage of target.  
To demonstrate the radiation delivered by the QBLT-guided 7-field irradiation, Fig. 7 shows 
examples of brain tissue sections, stained by DAPI and γ-H2AX. Due to the limitation of tissue 
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staining, we used two mice to demonstrate the 3D feature of the conformal irradiation. From the 
DAPI images, the high dense DNA area infers the GBM location (Fig. 7A1-2). The high-dense 
DNA region/GBM location is overlapped well with the irradiated area stained by the γ-H2AX (Fig. 
7B1-2, and C1-2). These results confirm the QBLT can guide SARRP effectively irradiate the 
GBM. It is worthwhile to note the γ-H2AX staining is highly sensitive to radiation and it is 
challenging to determine the exact threshold dose inducing the DNA double-strand breaks. We did 
not use γ-H2AX staining as quantitative measure, but a qualitative method to verify the GBM 
irradiation. In fact, even the dose outside GBM is low, γ-H2AX can still reveal one of the radiation 
beam passing through the brain (Fig. 7B2, double line arrow).     
Discussion 
A major challenge facing investigators is to correctly deliver radiation to animal models, so that 
their pre-clinical investigations are closely aligned with clinical practice. While CBCT-guided 
irradiators (1,2,4) provides valuable guidance capability, it is unable to localize soft tissue targets 
growing in a low image contrast environment. One may consider the contrast image for target 
delineation and guidance. It should be note that contrast CBCT is not an ideal modality to guide 
irradiation, due to fast clearance, and the use being limited to well-vascularized tumor models. 
Bioluminescence imaging thus offers an attractive solution. However, the intensity and distribution 
of commonly used surface BLI are nonlinearly dependent on the spatial location of internal source, 
tissue optical properties, animal shape and relative view of the animal to optical camera (31). Thus, 
the spatial distribution of bioluminescent tumor is not directly accessible for quantitation with 2D 
BLI. It is imperative for us to develop the 3D QBLT to accurately quantify the spatial distribution 
of the underlying tumor for radiation guidance. Recently, there are several studies showing the 
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potentiality of applying BLT for radiation guidance (11,17,32-34). The significance of this work 
is that we devised a comprehensive approach to systematically tackle the challenging of BLT for 
in vivo target delineation, quantify its uncertainties in localization, and present the practicality for 
radiation guidance first time.  
Considering the underdetermined nature, a known challenging for diffuse optical tomography, 
we chose the multi-projection and multi-spectral imaging acquisition to maximize input 
information for QBLT reconstruction (15,19). Accurate target reconstruction ultimately depends 
on if we have correct surface images as input. Ambient temperature does not only affect imaging 
acquisition time/experiment throughput (Fig. 3A), but also the accuracy of the multi-wavelength 
BLT reconstruction, closely related to the BL spectrum (Fig. 3B). We also presented that the 
kinetics of in vivo luciferin uptake is animal specific, which can affect the amplitude of the surface 
spectral data taken at different time point and potentially lead to erroneous BLT target localization 
(Fig. 3C-D). Furthermore, in non-contact imaging geometry, one major challenge is accounting 
for the light propagation from the skin to the optical detector. Existing approaches, typically using 
a model of the imaging system are usually computationally intensive or of limited accuracy (35,36). 
We have recently developed a novel approach in which, rather than directly using surface BLIs 
acquired at different wavelengths as used in conventional reconstruction method, the spectral 
derivative of the BLI data (the ratio of the BLIs at adjacent wavelengths) is used (16). As the BLIs 
at adjacent wavelengths encounter a near-identical system response, our approach eliminates the 
need for complicated system modeling. With our comprehensive approaches, we demonstrate the 
QBLT is able to define approximated GBM shape in vivo with the localization accuracy <1mm in 
average (Figs. 4C-E and S3).  
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The distribution of the BLT reconstructed volume depends on the choice of threshold, which 
determines the accuracy of radiation guidance. There are various threshold values used in optical 
tomography studies (37-39). The challenge of threshold selection in BLT is finding the value best 
representing actual target volume throughout study animals. We derived the strategy that 
determines the optimal threshold value 0.5 using dice coefficient for our animal cohort (Fig. 4F). 
Although the optimal threshold provides encouraging result of delineating the GBM volume based 
on the 3D BL distribution (Figs. 4C-E and S3), the QBLT-reconstructed volume is inevitable 
suffered from the resolution limitation and multiple scattering nature of diffusive optical 
tomography where actual tumor shape delineation is not achievable. This difficulty is similar to 
that of using positron emission tomography (PET) standard uptake value (SUV) for target 
delineation in clinical radiation therapy. We therefore innovated designing a radiation margin to 
account for the uncertainties of QBLT in target localization, i.e. positioning and volume. Without 
margin, a large variation of tumor coverage is expected, translated to large experimental 
uncertainties. In contrast, after adding a merely 0.5mm margin, the averaged tumor coverage was 
largely improved from 75 to 98% and the variation was significantly reduced (Fig. 5B).  
The margin is critical that it does not only effectively reduce the variation of target coverage 
and increase study reproducibility, but also provide a practical radiation planning volume PTV to 
make conformal RT possible. It is significant that now we can mimic clinic radiation therapy in 
orthotopic model to reduce normal tissue involvement and align in vivo experiment with clinic 
practice. From Fig. 6B1-B3 vs. C1-C3 and D, the optical-guided conformal irradiation is far 
superior than the traditional single field irradiation which can miss target, and may lead to wrong 
experiment conclusion due to large variation of tumor coverage (Fig. 6E). The similar D100, D50 
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and D2 between the GTV and GTVQBLT coverage further validate that with the PTVQBLT derived 
by proper threshold and margin selection, we can perform high contrast molecular optical-image-
guided irradiation.    
Our current work is limited by available collimator size from the commercial SARRP and 
forward treatment plan scheme. We designed the 7-field conformal plan (Fig. 6A1-3) with manual 
optimized gantry, and couch position, applied for our animal cohort. Ideally, as in modern clinic 
RT, one would use multi-leaf collimator (MLC) combined with inverse planning to design optimal 
collimator opening and beam orientation to provide conformal dose coverage. However, the pre-
clinical radiation research technology is still behind that of clinic RT, and the advances technique 
are still underdeveloped (40-42) and not readily available. With these technologies, one would 
expect the dose conformality (Fig. 6B1-3 and E) can be further improved. 
Although we have demonstrated QBLT-guided RT, the anatomical information provided by 
CBCT is indispensable. Without anatomical information, it could be challenging to guide 
irradiation with optical imaging alone. We utilized the CBCT image to help users identify region 
of interest and provide numerical mesh for BLT reconstruction. CBCT will also be used as the 
complementary imaging to support the interpretation of BLT results, which will allow users to 
distinguish the target bioluminescence from reconstruction artifacts. The importance of 
complementary use of functional and anatomical images, such as PET/CT, for radiation treatment 
planning and tumor response evaluation is well recognized in clinical practice (43,44). BL imaging 
has served as common surrogate of tumor viability in response to cancer therapy. In contrast, the 
anatomical imaging CBCT and MRI cannot detect tumor viability. By recovering 3D source 
distribution, we can use BLT quantity such as BL power to quantify the cell viability in response 
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to therapeutic intervention. We enthusiastically propose the next generation image-guided system, 
QBLT in this work. The QBLT complements CBCT-small animal radiation systems to provide 
researchers new capabilities for defining target shape for conformal RT, and to non-invasively 
quantify treatment outcome. 
Conclusion 
We presented a comprehensive approach to demonstrate QBLT-guided conformal irradiation 
for the orthotopic tumor model. For the first time, we innovated developing a radiation margin 
effectively overcoming the known challenge of target localization/delineation for optical 
tomography, which advances pre-clinical RT research close to clinic practice.  Our proposed 
QBLT platform will significantly enhance pre-clinical RT research with the capabilities of 
functional targeting beyond anatomical imaging as well as facilitating reproducibility of scientific 
studies. 
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Figure 1. System configuration; (A) is the photo of the QBLT system. The optical system consists 
of an optical assembly, a mobile cart and a moveable mouse bed. The optical assembly is motorized 
by the 1D linear stage and docked into the mouse bed. (B) shows the layout of the optical system; 
a 3-mirror system is cantilevered to attach the CCD camera-filter and light enclosure. The rotating 
3-mirror system reflects light from object to CCD camera for multi-projection imaging. (C) is the 
photo of transportable mouse bed with imaging markers (white plastic balls); the nose cone and 
gas tube were used to deliver anesthetic gas. (D) shows SARRP configuration for CBCT 
acquisition.  
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Figure 2. Validation of 2D BLIs mapped to the mesh surface from 3D CBCT; (A) the plastic balls 
taped on the mouse bed, within red rectangles, were used as the fiducial markers to retrieve 
geometric parameters for data mapping, and the balls taped on mouse phantom were used to assess 
the accuracy of the mapping. The axis of optical image coordinate at imaging plane was labeled 
as (u, v). (B) Validation of data mapping; red circles represent the location, directly measured from 
2D optical images, of the plastic balls on the mouse phantom and the blue cross represent the 
corresponding location calculated from our calibration routine by the ball position shown in 3D 
CBCT and optimized geometric parameters. (C) shows 2D BLIs (colormap, 650 nm) from a self-
illuminated rectangular light source embedded in the mouse phantom at -900, 00 and 900 projection. 
(D) shows the image of the 3 projections BLI data (C) mapped onto the surface of the numerical 
mesh generated from the phantom CBCT image. Data with value larger than 10% of the maximum 
value is displayed in Fig. (C and D). 
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Figure 3. Temperature effect on bioluminescence signal in vitro and quantification of inter-animal 
signal variation; (A) is in vitro light intensity of GL261-Luc2 cells vs. ambient temperature (n = 
5). The error bar represents standard deviation. (B) shows the change of normalized emission 
spectrum of GL261-Luc2 for 24 °C (n = 6) and 37 °C (n = 20) in vitro. The error bar represents 
standard deviation. (C) shows the dynamic change of in vivo bioluminescence signal for 3 GBM-
bearing mice, normalized to maximum intensity. (D) Mouse 3 from Fig. C is used as an example 
to illustrate the formation of the overall time-resolved curve combined from 0°, -90° and 90° 
projection. 
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Figure 4. In vivo QBLT reconstruction and threshold determination; (A) is surface BLIs 
(colormap, 650nm) of a 2nd week GBM-bearing mouse taken at -90°, 0°, and 90° projection. (B) 
shows the image of the 3 projection BLIs (A) mapped onto the surface of the numerical mesh 
generated from the mouse CBCT image. Data with value larger than 10% of the maximum among 
all the 3 projections is displayed in (A) and (B). The overlap of QBLT delineated GBM (GTVQBLT, 
heat map) and contrast-delineated GBM (GTV, blue contour) were shown in (C) transverse, (D) 
sagittal, and (E) coronal views. A threshold of 0.5 of maximum QBLT reconstructed value was 
used to display the GTVQBLT. (F) is the boxplot of the Dice coefficient between GTVQBLT and GTV 
vs. threshold of maximum QBLT reconstructed value (n=10); each red circle represents one mouse 
data. The asterisk (*) indicates no significant difference (P > 0.05, n = 10) of Dice coefficient 
between the threshold of 0.5 and 0.6 groups.  
 
 
34 
 
 
 
 
 
Figure 5. Margin design for QBLT-guided irradiation; (A) shows a uniform margin 0.5mm added 
to a GTVQBLT (heat map) to form a PTVQBLT (cyan). The GTV is delineated by blue contour. (B) 
is the boxplot of tumor coverage (red circle, left axis) and normal tissue coverage (blue cross, right 
axis) versus margin expansion for 2nd week old GBM; the asterisk (*) indicates no significant 
difference (p>0.05, n=10) of the tumor coverage between 0.5 and 1mm margin groups, and 
between 0.5 and 1.5mm margin groups. Each circle and cross represent one mouse data point, and 
total 10 mice were entered to this study. 
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Figure 6. In vivo QBLT-guided conformal irradiation; (A1-A3) show a representative case (same 
animal as shown in the Fig. 5A) of a 7-field non-coplanar plan for a 2nd week GBM bearing mouse 
in transverse, sagittal and coronal views, respectively; the contrast-labelled GBM is delineated in 
blue contour. Five coplanar fields (couch at 0°, and gantry at -60°, 60°, 90°, 140° and 180°) were 
indicated by the white arrows in Fig. A1-A3 and two non-coplanar fields (couch at -40° and 40°, 
gantry at -60°) were indicated by the yellow dashed arrows in Fig. A3. The weighting of each 
irradiation field is 12.5% except for the beam at couch 0° and gantry 180° with weighting of 25%. 
The corresponding dose distributions are shown in Fig. (B1-B3) with 5Gy as the prescribed dose 
to cover the PTVQBLT. For comparison, (C1-C3) are the dose distributions of single beam delivery, 
5Gy prescribed to the isocenter (yellow dot) 3mm away from the surgical opening. (D) is the 
corresponding DVH of the 7-fields QBLT-guided (B1-B3) and single field (C1-C3) irradiation for 
PTVQBLT, GTVQBLT, GTV, and normal tissue (NT). (E) is the boxplots of dose deposited at 100% 
(D100), 50% (D50) and 2%(D2) of the target volume for GTV under the single field irradiation, GTV 
under the 7-fields QBLT-guided irradiation, and GTVQBLT under the 7-fields QBLT-guided 
irradiation (n=10). Black dashed line indicates the prescribed dose of 5Gy. The asterisk (*) 
indicates no significant difference (P>0.05, n=10) of D100, D50 and D2 between the GTV and 
GTVQBLT groups for the 7-fields treatment plan. 
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Figure 7. Pathological confirmation of in vivo QBLT-guided conformal irradiation; (A1-B1 and 
A2-B2) are DAPI, and γ-H2AX staining in transverse and coronal brain sections from two mice, 
respectively. In (B1-B2), white solid, double dash, and double line arrows point to the GBM, 
normal tissue, and normal tissue irradiated area, respectively. (C1 and C2) are the composited 
images of DAPI and γ-H2AX staining. 
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(For the sake of convenience, the references used in the supplementary section are listed at the 
end.) 
Supplementary material 
1. Characterization of optical system 
1.1 Imaging depth of field and focal plane 
To acquire clear images of imaged object at different projections, we first need to know the 
imaging depth of field (DOF) of our optical system. We used a 45° wedge with line pairs on its 
hypotenuse to measure the imaging DOF (Fig. S1A). The wedge was placed on the mouse bed 
(Fig. 1B). The photo of the ruler was acquired at 0° imaging projection with 1x1 binning. The 
contrast of a line pair is defined as 
𝐼𝑚𝑎𝑥−𝐼𝑚𝑖𝑛
𝐼𝑚𝑎𝑥+𝐼𝑚𝑖𝑛
, where Imax and Imin are the maximum and minimum 
intensity of the white line and black line of a line pair shown in Fig. S1A, respectively. We mapped 
the contrast of the line pairs to the physical height above the mouse bed (Fig. S1B). The DOF is 
defined as the physical range, corresponding to the height above the mouse bed, of the contrast 
larger than 30% of the normalized maximum value, which was calculated from the 1 line pair 
(lp)/mm. The DOF of our optical system is at 21±0.4 mm (n=3). We also use this value as a quality 
control baseline to maintain constant imaging performance. 
1.2 Focal plane 
From our mice (C57BL/6) cohort, the height of mouse head above mouse bed and the width 
of mouse head are 19.2 ± 0.6 and 13.6 ± 0.7 mm (n=10). With the DOF as 21 mm, we set the focal 
plane at 10-15 mm above mouse bed, so we can acquire clear BLIs of mouse head at all three 
projections (-90°, 0° and 90°). Fig. S1B shows a representative result of the image contrast of the 
1 lp/mm line pairs, we estimated the focal plane at 11.3 mm above mouse bed by examining the 
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maximum contrast position of the line pairs. The average focal plane location with standard 
deviation is at 11.1 ± 1.8 mm and image depth range is from 2.6 ± 0.4 to 23.6 ± 0.4 mm (n=3) 
above the mouse bed. 
1.3 Pixel scale 
The pixel scale is the corresponding physical size of CCD pixel at imaging plane. We measured 
the pixel scale with a ruler placed horizontally on the focal plane. The physical distance between 
the scales on the ruler was used to calculate the pixel scale which is about 0.117 mm per CCD 
pixel.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              
1.4 Image distortion 
We placed a paper with a dot grid on the mouse bed (10 × 10 cm2 field of view around the 
image center at mirror 0°). Photo image at 1 × 1 binning is acquired. To examine image distortion, 
we compared the measured distance of the dot center to the image center to the actual distance. No 
distortion was observed in our system. 
1.5 Optical background 
It is important to keep low optical background for BLT application because long exposure time 
may be needed to image cases with weak bioluminescent signal. Any light leaked into the imaging 
chamber can possibly contaminate bioluminescent image (BLI), which affects the BLT 
reconstruction accuracy. To check the optical background signal level of our system, we use 120s 
exposure time to take open field (without filters) images (8x8 binning, 4x pre-amplifier gain and 
1MHz readout rate) at -90°, 0° and 90° projection. A region of interest (ROI, 90 pixel x 90 pixel, 
10 cm x 10 cm) around the image center was selected for data analysis (Fig. S1C). The background 
level is about 860 counts per pixel. We subtracted the background signal from our BLI data during 
post-processing.  
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2. System-specific spectrum of GBM cells tagged with different luciferase genes 
The release of bioluminescent light is based on the interaction of the enzyme luciferase with 
luminescent substrate luciferin. The spectrum of bioluminescence light depends on the type of 
luciferase. We measured the emission spectrum of GL261-Luc2 and GL261-RedFluc 
 
Figure S2. The normalized system-specific spectrum of GL261-Luc2 (yellow square, n = 20) 
and GL261-RedFluc (red circle, n = 5) cells in vitro was measured at 37 0C in our QBLT system. 
The error bar represents standard deviation. 
 
Figure S1. (A) Photo of a 45o wedge with lines pairs (from left to right, the line pairs are 2 lp/mm, 
1 lp/mm and 0.5 lp/mm); the wedge was placed on the mouse bed. The red arrow indicates the 
height increasing direction along with the line pairs. (B) shows the contrast change of the 1 lp/mm 
along the red arrow in (A). (C) is a representative optical background image; the dashed square 
shows the region of interest for background signal analysis. The unit is in CCD counts and the 
maximum count is 65535. 
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(PerkinElmer, Inc., Waltham, MA) with the method described in system-specific cell spectrum 
section using our QBLT system (Fig. S2). It clearly shows the spectrum of GL261-RedFluc cell 
was red-shifted compared to that of GL261-Luc2 cell.  
3. In vivo QBLT results 
In Fig. S3, we present all the in vivo QBLT results of the 2nd week GBM bearing mice (n=10) 
overlapped with contrast CBCT images. These mice were used for statistical analysis in Figs. 4F, 
5B, and 6E. The parameters used in QBLT reconstruction are as follows. 
The mesh generation parameters used in the QBLT reconstruction are listed below: 
1) Lower bound for the angles of surface mesh facets: 30°; 
2) Upper bound for the distances between facet circumcenters and the centers of their surface 
Delaunay balls: 1 mm; 
3) Upper bound for the radius of surface Delaunay balls: 0.7 mm; 
4) Upper bound for the circumradius of mesh tetrahedral elements: 0.76 mm;  
5) Upper bound for the radius-edge ratio of mesh tetrahedral elements: 1. 
The optical properties used in the QBLT reconstruction are listed in Table S1. 
The relative system-specific spectrum of GL261-Luc2 cells at 610, 630 and 650 nm used in 
the QBLT reconstruction are 0.916, 0.674 and 0.389, respectively. 
Table S1. Optical properties of mouse brain 
Wavelength (nm) 610 630 650 
Absorption coefficient, 𝜇𝑎 (mm
-1) 0.1610 0.0820 0.0577 
Reduced scattering coefficient, 𝜇𝑠
′  (mm-1) 1.56 1.51 1.46 
Refractive index, n 1.4 
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The parameters used to select surface BLI data as input for the QBLT reconstruction are listed 
below: 
1) Upper bound for the angle between the norm of surface data and camera view direction: 
60°; 
2) Lower bound for the threshold of the maximum detector value used to select surface data 
as the input for QBLT reconstruction: 0.1; 
A numerical stabilized factor of 100 was used to scale up the BLI measurement data as the 
 
Figure S3. The overlap of contrast-delineated GBM (gross target volume, GTV, blue contour) 
and QBLT delineated GBM (GTVQBLT, heat map) were shown in coronal (A1-J1), transverse 
(A2-J2) and sagittal (A3-J3) views for 10 mice. A 0.5mm margin was added to the GTVQBLT to 
form PTVQBLT. 
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input for QBLT reconstruction. In the Eq. (4), the mapping function depends on the term 
log𝑏𝜆𝑖𝑛
𝑏𝜆𝑖𝑛
 , 
where 𝑏𝜆𝑖 is BLI data and n is a point specific angular dependent offset (n is between 0 to 1). To 
make the mapping function less sensitive to the value of 
log𝑏𝜆𝑖𝑛
𝑏𝜆𝑖𝑛
 and therefore stabilize the 
reconstruction routine, we empirically scaled up the BLI measurement data 𝑏𝜆𝑖by 100. We later 
divided the reconstruction solution by the factor, 100, to eliminate the numerical impact on the 
reconstructed power density.  
4. Image segmentation of tumor volume 
Contrast CBCT was used to define the gross target volume (GTV) of GBM bearing mice. The 
contrast image of the GBM bearing mouse was taken in our in-house high resolution CBCT system 
(1). The mouse head region was cropped from the SARRP CBCT and contrast CBCT image. We 
registered the cropped contrast CBCT image with the SARRP CBCT image based on skull rigid 
alignment using the General Registration (BRAINS) module from 3D Slicer (2), since the SARRP 
CBCT was used for the QBLT reconstruction and radiation treatment planning. After image 
registration, we selected a range of CBCT values to determine the segment mask best representing 
the contrast-labelled tumor region using the Segment Editor module in 3D slicer. The range of the 
CBCT value was chosen to remove skull area and normal tissue region. Within the segment mask, 
a paint brush was used to segment GTV slice by slice, followed by erase tool to manually remove 
normal tissue region not labelled by contrast agent at 3 views (transverse, coronal and sagittal). 
We visually examined the segmented GTV to confirm the GTV contour reasonably overlapped 
with contrast labelled tumor area. We also compared the GTV contour based on the segmentation 
method described in this work to that based on in-house developed iterative approach proposed in 
our previous publication (3) (Fig. S4). The Dice coefficient of the segmented GTV from these two 
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methods is 0.88 ± 0.03 (n = 3). The deviation of CoMs and volumes of the segmented GTV 
retrieved from both methods is 0.14 ± 0.11 mm and 0.6 ± 0.9 mm3 (n = 3), respectively. This result 
suggested that our GBM volume determination is robust and our end-results (Figs. 4F, 5B and 6E) 
are unlikely depending on different segmentation methods. Because there is significant amount of 
labor work involved and the segmentation is pertained to single viewing direction for our 
previously published method, we chose the 3D Slicer approach for the GTV segmentation in this 
work.  
5. Immuno-histochemical staining 
γ-H2AX assay reflects the presence of DNA double-strand breaks (4). We used the γ-H2AX 
assay to detect the γ-H2AX foci in 2D brain tissue section to identify the irradiation area introduced 
by the QBLT-guided RT, and 4’, 6-diamidino-2-phenylindole (DAPI) staining to visualize cell 
nuclei. 
The mouse brain was excised within one hour after irradiation, and the brain was infused in 
10% buffered formalin for 24 hours at room temperature. The fixed brain was sent to the Johns 
Hopkins Oncology Tissue Service Center for paraffin embedding and sectioning at 4-μm intervals. 
 
Figure S4. (A-B) show a representative result of GTV segmentation from the contrast CBCT 
image based on the 3D Slicer method and our previously published method (3), respectively. 
The contours in (A) and (B) indicate the segmented GTV. (C) shows the overlap of segmented 
GTVs from (A) and (B). 
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For γH2AX staining, we deparaffinized and rehydrated the sections in sequence of  “5 min Xylene 
(Fisher Chemical, Fisher Scientific, Fair Lawn, NJ), 5 min Xylene, 3 min 100% EtOH (Pharmco, 
Greenfield Global, Brookfield, CT), 3 min 100% EtOH, 3 min 95% EtOH, 3 min 95% EtOH, 3 
min 70% EtOH, 3 min 50% EtOH and 5 min distilled water”. To retrieve all of antigens (including 
γH2AX and nonspecific binding sites) on the sections, we submerged the sections into 10-mM 
citrate buffer (Dako, Carpinteria, CA) at pH 6 and steamed them for 45 minutes at 95 °C. To block 
nonspecific binding sites for ensuring the binding of primary antibodies to γ-H2AX foci, we 
applied 4% bovine serum albumin (Sigma Life Science, Sigma-Aldrich, St. Louis, MO) to the 
sections for 30 min. After the preprocessing procedures, the section was incubated with primary 
antibody (Phospho-Histone H2A.X (Ser139) (20E3) Rabbit mAb, 1:500, Cell Signaling 
Technology, Danvers, MA) against phosphorylated γH2AX over night at 4 °C, and followed by 
the secondary antibody (Alexa Fluor 594 goat anti-rabbit IgG (H+L), 1:500, Life Technologies 
Corporation, Eugene, Oregon) for 1 hour at room temperature. The brain section was 
counterstained with DAPI for 30 minutes. After dripping antifade medium Vectashield (Vector 
Laboratories, Burlington, ON, Canada) to the sections, we mounted coverslips onto the sections. 
The edges of coverslips were sealed with clear nail polish. 
The stained brain section was visualized by fluorescent imaging with a 10x objective on a high-
content imager (ImageXpress Micro, Molecular Devices, San Jose, CA). Excitation/emission 
filters were set at 377/447 and 590/617 nm for nuclei and γ-H2AX foci labels, respectively. We 
used the imager to acquire sub images (2.6 μm/pixel) of the tissue section, and then combined the 
sub images to generate an image of the whole tissue section.  
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